Crohn’s & Colitis Congress
Conference Coverage
Consider cultural differences in IBD diet planning
Clinicians should incorporate culturally sensitive discussions and recommendations into interactions with patients with inflammatory bowel disease...
Conference Coverage
Herbal combination tames active UC in small study
Derivatives of an intensely yellow spice and an intensely blue dye combined to resolve active ulcerative colitis in a small randomized trial.
Conference Coverage
Adult stem cells can heal intractable perianal Crohn’s fistulae
Many patients experienced complete healing within 3 months of a single infusion of mesenchymal stem cells.
Conference Coverage
Gut enzymes fingered in some 5-ASA treatment failures
Patients with inflammatory bowel disease who had three or four specific acetyltransferases in their gut microbiota had a threefold higher risk for...
Conference Coverage
Food additives may exacerbate IBD
Emulsifiers and thickeners added to food in processing may contribute to inflammation and changes in gut microbiota.
Conference Coverage
Proof lacking for dual-targeted therapy benefit in IBD
Questions remain unanswered about the effectiveness of combination biologic treatment for inflammatory bowel disease.
Conference Coverage
Handle with care: Managing IBD in older patients
Patients 60 and older with chronic or newly diagnosed IBD may have comorbidities or use medications that can interfere with IBD therapies.
Conference Coverage
Malnutrition common in patients with IBD
As many as 85% of patients hospitalized with IBD may be malnourished, dietary experts cautioned.
Conference Coverage
Breakthrough COVID-19 milder in vaccinated patients with IBD
Patients with inflammatory bowel disease who are vaccinated but still develop COVID experience milder disease than those who are unvaccinated.
Conference Coverage
ARFID or reasonable food restriction? The jury is out
Don’t jump to conclusions about avoidant restrictive food intake disorder in patients with gastrointestinal diseases, psychologists advise.
Conference Coverage
Can smoke exposure inform CRC surveillance in IBD?
A prospective analysis showed heightened risk for colorectal neoplasia in some subgroups, but the analysis didn’t account for inflammation.
Conference Coverage
Vedolizumab looks safer than anti-TNF drugs in older adults with IBD
An analysis of a Medicare claims database finds vedolizumab is associated with efficacy similar to that of anti-TNF inhibitors, with fewer...
Conference Coverage
Defining wellness in IBD
Psychobehavioral researcher says it goes beyond just symptom management and quality of life measures.
Conference Coverage
NAFLD linked to worse outcomes in IBD
New nationwide analysis suggests involvement of nonmetabolic factors.
Conference Coverage
Racial, social inequities persist in IBD
Three in four patients are White, but there is growing appreciation of the diversity of the population and the need for equity in care.